Skip to main content

Cardiotoxicity with 5‐fluorouracil and capecitabine: more than just vasospastic angina

Buy Article:

$43.00 plus tax (Refund Policy)

In this case series we present a variety of different cardiac toxicities with 5‐fluorouracil and its pro‐drug capecitabine, including myocardial infarction, cardiomyopathy, sinoatrial and atrioventricular node dysfunction, tako‐tsubo cardiomyopathy and QT prolongation with torsade‐de pointes ventricular tachycardia. We stress the fact that while vasospasm is a well‐recognized side‐effect of this class of chemotherapeutic agent, broader cardiotoxicity is commonly seen and an increased awareness of the range of toxicity is necessary if repeat toxicity is to be avoided.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: capecitabine; cardiotoxicity; fluorouracil

Document Type: Research Article

Affiliations: Departments of Cardiology and

Publication date: 2010-04-01

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more